SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Steve Harmon who wrote (1711)11/20/1998 1:42:00 PM
From: Walter Morton  Respond to of 2742
 
Who is Kirtland & Ellis? They got 250,000 warrants exercisable at $.50 before 12/2/2000.

Apparently Kirtland & Ellis think CIST will sell for more than $.22 between now and the year 2000.

I like the formula CIST used to determine the convertibility of the shares. The warrants could be converted for less than 250,000 shares and for a maximum of 250,000.

I did not see any excessive issuances of warrants relative to the number of shares outstanding.



To: Steve Harmon who wrote (1711)11/20/1998 1:55:00 PM
From: Walter Morton  Read Replies (2) | Respond to of 2742
 
Steve, are you referring to the fact that Genome Securities, Inc. (GSI) will get paid even if they don't have any results?

It may be prudent to keep an eye on GSI. To see if this new start-up company is being effective for any of its other clients.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News